Design or screening of drugs for the treatment of Chagas disease: what shows the most promise?
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design or screening of drugs for the treatment of Chagas disease: what shows the most promise?
Authors
Keywords
-
Journal
Expert Opinion on Drug Discovery
Volume 8, Issue 12, Pages 1479-1489
Publisher
Informa Healthcare
Online
2013-09-30
DOI
10.1517/17460441.2013.845554
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chagas' Disease as a Foodborne Illness
- (2016) KAREN SIGNORI PEREIRA et al. JOURNAL OF FOOD PROTECTION
- In VitroandIn VivoStudies of the Antiparasitic Activity of Sterol 14α-Demethylase (CYP51) Inhibitor VNI against Drug-Resistant Strains of Trypanosoma cruzi
- (2013) Maria de Nazaré Correia Soeiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Transmission and Epidemiology of Zoonotic Protozoal Diseases of Companion Animals
- (2013) Kevin J. Esch et al. CLINICAL MICROBIOLOGY REVIEWS
- Treatment of Chagas' disease with itraconazole: electrocardiographic and parasitological conditions after 20 years of follow-up
- (2013) W. Apt et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- VNI Cures Acute and Chronic Experimental Chagas Disease
- (2013) Fernando Villalta et al. JOURNAL OF INFECTIOUS DISEASES
- Antitrypanosomal Lead Discovery: Identification of a Ligand-Efficient Inhibitor of Trypanosoma cruzi CYP51 and Parasite Growth
- (2013) Grasiella Andriani et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel amidines and analogues as promising agents against intracellular parasites: a systematic review
- (2013) M. N. C. SOEIRO et al. PARASITOLOGY
- Childhood Parasitic Infections Endemic to the United States
- (2013) Meagan A. Barry et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Neglected Infections of Poverty in Texas and the Rest of the United States: Management and Treatment Options
- (2012) M A Barry et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Efficacy of voriconazole in a murine model of acute Trypanosoma cruzi infection
- (2012) J. E. N. Gulin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Benznidazole-Resistance in Trypanosoma cruzi Is a Readily Acquired Trait That Can Arise Independently in a Single Population
- (2012) Ana Maria Mejia et al. JOURNAL OF INFECTIOUS DISEASES
- Analogues of Fenarimol Are Potent Inhibitors of Trypanosoma cruzi and Are Efficacious in a Murine Model of Chagas Disease
- (2012) Martine Keenan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Organocatalytic, Enantioselective Synthesis of VNI: A Robust Therapeutic Development Platform for Chagas, a Neglected Tropical Disease
- (2012) Mark C. Dobish et al. ORGANIC LETTERS
- Chagas disease: What is known and what should be improved: a systemic review
- (2012) José Rodrigues Coura et al. Revista da Sociedade Brasileira de Medicina Tropical
- CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffolds
- (2012) Tatiana Y. Hargrove et al. International Journal for Parasitology-Drugs and Drug Resistance
- Trypanosoma cruzi and Chagas' Disease in the United States
- (2011) C. Bern et al. CLINICAL MICROBIOLOGY REVIEWS
- Sterol 14alpha-Demethylase (CYP51) as a Therapeutic Target for Human Trypanosomiasis and Leishmaniasis
- (2011) Galina I. Lepesheva et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Methodological advances in drug discovery for Chagas disease
- (2011) Juan M Bustamante et al. Expert Opinion on Drug Discovery
- Substrate Preferences and Catalytic Parameters Determined by Structural Characteristics of Sterol 14α-Demethylase (CYP51) fromLeishmania infantum
- (2011) Tatiana Y. Hargrove et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural complex of sterol 14α-demethylase (CYP51) with 14α-methylenecyclopropyl-Δ7-24, 25-dihydrolanosterol
- (2011) Tatiana Y. Hargrove et al. JOURNAL OF LIPID RESEARCH
- Novel 3-Nitro-1H-1,2,4-triazole-Based Aliphatic and Aromatic Amines as Anti-Chagasic Agents
- (2011) Maria V. Papadopoulou et al. JOURNAL OF MEDICINAL CHEMISTRY
- First Century of Chagas' Disease: An Overview on Novel Approaches to Nifurtimox and Benznidazole Delivery Systems
- (2011) Claudio J. Salomon JOURNAL OF PHARMACEUTICAL SCIENCES
- Antitrypanosomal Therapy for Chronic Chagas' Disease
- (2011) Caryn Bern NEW ENGLAND JOURNAL OF MEDICINE
- Drug Developers Finally Take Aim at a Neglected Disease
- (2011) M. Leslie SCIENCE
- Drug discovery and development for neglected diseases: the DNDi model
- (2011) Jean-Robert Ioset et al. Drug Design Development and Therapy
- Successful Treatment with Posaconazole of a Patient with Chronic Chagas Disease and Systemic Lupus Erythematosus
- (2010) María-Jesús Pinazo et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Effects of Ravuconazole Treatment on Parasite Load and Immune Response in Dogs Experimentally Infected with Trypanosoma cruzi
- (2010) L. d. F. Diniz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New insights in Chagas disease treatment
- (2010) J.A. Urbina DRUGS OF THE FUTURE
- Structural Insights into Inhibition of Sterol 14α-Demethylase in the Human PathogenTrypanosoma cruzi
- (2010) Galina I. Lepesheva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chagas disease
- (2010) Anis Rassi et al. LANCET
- Chagas disease: pushing through the pipeline
- (2010) Julie Clayton NATURE
- Chagas disease: a new worldwide challenge
- (2010) José Rodrigues Coura et al. NATURE
- An insight into the antifungal pipeline: selected new molecules and beyond
- (2010) Luis Ostrosky-Zeichner et al. NATURE REVIEWS DRUG DISCOVERY
- Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches
- (2009) Julio A. Urbina ACTA TROPICA
- Chagas disease: A Latin American health problem becoming a world health problem
- (2009) Gabriel A. Schmunis et al. ACTA TROPICA
- Crystal Structures of Trypanosoma brucei Sterol 14α-Demethylase and Implications for Selective Treatment of Human Infections
- (2009) Galina I. Lepesheva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Indomethacin Amides as a Novel Molecular Scaffold for TargetingTrypanosoma cruziSterol 14α-Demethylase
- (2009) Mary E. Konkle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ergosterol biosynthesis and drug development for Chagas disease
- (2009) Julio A Urbina MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Benznidazole and Chagas disease: can an old drug be the answer to an old problem?
- (2008) Charles Mady et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Trypanosoma cruzitargets for new chemotherapeutic approaches
- (2008) Maria Nazaré C Soeiro et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- CYP51: A Major Drug Target in the Cytochrome P450 Superfamily
- (2008) Galina I. Lepesheva et al. LIPIDS
- A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes
- (2008) Shane R. Wilkinson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neglected Infections of Poverty in the United States of America
- (2008) Peter J. Hotez PLoS Neglected Tropical Diseases
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started